Carregant...
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
BACKGROUND: Fingolimod (FTY) and dimethyl fumarate (DMF) are multiple sclerosis (MS) oral therapies that became available in 2010 and 2013, respectively. OBJECTIVE: The objective of this article is to compare discontinuation rates, efficacy, and adverse events (AEs) of FTY and DMF over two years. ME...
Guardat en:
| Publicat a: | Mult Scler J Exp Transl Clin |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564884/ https://ncbi.nlm.nih.gov/pubmed/28839949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317725102 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|